This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Andrews, K. L. Articles by Miner, J. H. Search for Related Content PubMed PubMed Citation Articles by Andrews, K. L. Articles by Miner, J. H.

(American Journal of Pathology. 2002;160:721-730.)
© 2002 American Society for Investigative Pathology

Animal Models

Quantitative Trait Loci Influence Renal Disease Progression in a Mouse Model of Alport Syndrome

Kaya L. Andrews^*, Jacqueline L. Mudd^*, Cong Li^* and Jeffrey H. Miner^*

From the Renal Division,^*
Department of InternalMedicine, and Department of Cell Biology andPhysiology,
Washington University School ofMedicine, St. Louis, Missouri

Abstract

Alport syndrome is a human hereditary glomerulonephritis which results in end-stage renal failure (ESRF) in most cases. It is caused by mutations in any one of the collagen 3(IV), 4(IV), or 5(IV) chain genes (COL4A3-COL4A5). Patients carrying identical mutations can exhibit very different disease courses, suggesting that other genes or the environment influence disease progression. We previously generated a knockout mouse model of Alport syndrome by mutating Col4a3. Here, we show that genetic background strongly influences the timing of onset of disease and rate of progression to ESRF in these mice. On the 129X1/SvJ background, Col4a3 -/- mice reached ESRF at 66 days of age, while on the C57BL/6J background, the mean age at ESRF was 194 days of age. This suggests the existence of modifier genes that influence disease progression. A detailed histopathological analysis revealed that glomerular basement membrane lesions typical of Alport syndrome were significantly more frequent in homozygotes on the 129X1/SvJ background than on the C57BL/6J background as early as two weeks of age, suggesting that modifier genes act by influencing glomerular basement membrane structure. Additional data indicated that differential physiological responses to basement membrane splitting also underlie the differences in disease progression. We attempted to map the modifier genes as quantitative trait loci (QTLs) using age at ESRF as the quantitative trait. Genome scans were performed on mice at the two extremes in a cohort of mutant F1 x C57BL/6J backcross mice. Analysis with Map Manager QT revealed QTLs linked to markers on chromosomes 9 and 16. A more detailed understanding of how these QTLs act could lead to new approaches for therapy in diverse renal diseases.

This article has been cited by other articles:

				J. Ratelade, T. A. Lavin, A. O. Muda, L. Morisset, G. Mollet, O. Boyer, D. S. Chen, A. Henger, M. Kretzler, N. Hubner, et al. Maternal Environment Interacts with Modifier Genes to Influence Progression of Nephrotic Syndrome J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1491 - 1499. [Abstract] [Full Text] [PDF]

				D. Cosgrove, D. T. Meehan, D. Delimont, A. Pozzi, X. Chen, K. D. Rodgers, R. M. Tempero, M. Zallocchi, and V. H. Rao Integrin {alpha}1{beta}1 Regulates Matrix Metalloproteinases via P38 Mitogen-Activated Protein Kinase in Mesangial Cells: Implications for Alport Syndrome Am. J. Pathol., March 1, 2008; 172(3): 761 - 773. [Abstract] [Full Text] [PDF]

				C. E. Kashtan The Wages of Thin J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2800 - 2802. [Full Text] [PDF]

				E. I. Prodromidi, R. Poulsom, R. Jeffery, C. A. Roufosse, P. J. Pollard, C. D. Pusey, and H. T. Cook Bone Marrow-Derived Cells Contribute to Podocyte Regeneration and Amelioration of Renal Disease in a Mouse Model of Alport Syndrome Stem Cells, November 1, 2006; 24(11): 2448 - 2455. [Abstract] [Full Text] [PDF]

				V. H. Rao, D. T. Meehan, D. Delimont, M. Nakajima, T. Wada, M. A. Gratton, and D. Cosgrove Role for Macrophage Metalloelastase in Glomerular Basement Membrane Damage Associated with Alport Syndrome Am. J. Pathol., July 1, 2006; 169(1): 32 - 46. [Abstract] [Full Text] [PDF]

				J. S. Kang, X.-P. Wang, J. H. Miner, R. Morello, Y. Sado, D. R. Abrahamson, and D.-B. Borza Loss of {alpha}3/{alpha}4(IV) Collagen from the Glomerular Basement Membrane Induces a Strain-Dependent Isoform Switch to {alpha}5{alpha}6(IV) Collagen Associated with Longer Renal Survival in Col4a3-/- Alport Mice J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1962 - 1969. [Abstract] [Full Text] [PDF]

				M. B. Shannon, B. L. Patton, S. J. Harvey, and J. H. Miner A Hypomorphic Mutation in the Mouse Laminin {alpha}5 Gene Causes Polycystic Kidney Disease J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1913 - 1922. [Abstract] [Full Text] [PDF]

				X.-P. Wang, A. B. Fogo, S. Colon, G. Giannico, S. R. Abul-Ezz, J. H. Miner, and D.-B. Borza Distinct Epitopes for Anti-Glomerular Basement Membrane Alport Alloantibodies and Goodpasture Autoantibodies within the Noncollagenous Domain of {alpha}3(IV) Collagen: A Janus-Faced Antigen J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3563 - 3571. [Abstract] [Full Text] [PDF]

				M. A. Gratton, V. H. Rao, D. T. Meehan, C. Askew, and D. Cosgrove Matrix Metalloproteinase Dysregulation in the Stria Vascularis of Mice with Alport Syndrome: Implications for Capillary Basement Membrane Pathology Am. J. Pathol., May 1, 2005; 166(5): 1465 - 1474. [Abstract] [Full Text] [PDF]

				Z. Zheng, K. M. Schmidt-Ott, S. Chua, K. A. Foster, R. Z. Frankel, P. Pavlidis, J. Barasch, V. D. D'Agati, and A. G. Gharavi A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse PNAS, February 15, 2005; 102(7): 2502 - 2507. [Abstract] [Full Text] [PDF]

				R. Korstanje and K. DiPetrillo Unraveling the genetics of chronic kidney disease using animal models Am J Physiol Renal Physiol, September 1, 2004; 287(3): F347 - F352. [Abstract] [Full Text] [PDF]

				M. N. Rheault, S. M. Kren, B. K. Thielen, H. A. Mesa, J. T. Crosson, W. Thomas, Y. Sado, C. E. Kashtan, and Y. Segal Mouse Model of X-Linked Alport Syndrome J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1466 - 1474. [Abstract] [Full Text] [PDF]

				S. Roselli, L. Heidet, M. Sich, A. Henger, M. Kretzler, M.-C. Gubler, and C. Antignac Early Glomerular Filtration Defect and Severe Renal Disease in Podocin-Deficient Mice Mol. Cell. Biol., January 15, 2004; 24(2): 550 - 560. [Abstract] [Full Text] [PDF]

				M. Zeisberg, C. Bottiglio, N. Kumar, Y. Maeshima, F. Strutz, G. A. Muller, and R. Kalluri Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1060 - F1067. [Abstract] [Full Text]

				C. L. Moulson, D. R. Martin, J. J. Lugus, J. E. Schaffer, A. C. Lind, and J. H. Miner Cloning of wrinkle-free, a previously uncharacterized mouse mutation, reveals crucial roles for fatty acid transport protein 4 in skin and hair development PNAS, April 29, 2003; 100(9): 5274 - 5279. [Abstract] [Full Text] [PDF]

				M.-T. Bihoreau, N. Megel, J. H. Brown, B. Kranzlin, L. Crombez, Y. Tychinskaya, J. Broxholme, S. Kratz, V. Bergmann, S. Hoffman, et al. Characterization of a major modifier locus for polycystic kidney disease (Modpkdr1) in the Han:SPRD(cy/+) rat in a region conserved with a mouse modifier locus for Alport syndrome Hum. Mol. Genet., September 1, 2002; 11(18): 2165 - 2173. [Abstract] [Full Text] [PDF]

				C. E. Kashtan Animal models of Alport syndrome Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1359 - 1362. [Full Text] [PDF]